Correlation Between Dine Brands and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dine Brands and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dine Brands and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dine Brands Global and Carmell Therapeutics, you can compare the effects of market volatilities on Dine Brands and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dine Brands with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dine Brands and Carmell Therapeutics.
Diversification Opportunities for Dine Brands and Carmell Therapeutics
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dine and Carmell is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Dine Brands Global and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Dine Brands is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dine Brands Global are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Dine Brands i.e., Dine Brands and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Dine Brands and Carmell Therapeutics
Considering the 90-day investment horizon Dine Brands Global is expected to under-perform the Carmell Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Dine Brands Global is 8.05 times less risky than Carmell Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Carmell Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 15.00 in Carmell Therapeutics on September 14, 2024 and sell it today you would lose (10.21) from holding Carmell Therapeutics or give up 68.07% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 34.2% |
| Values | Daily Returns |
Dine Brands Global vs. Carmell Therapeutics
Performance |
| Timeline |
| Dine Brands Global |
| Carmell Therapeutics |
Dine Brands and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dine Brands and Carmell Therapeutics
The main advantage of trading using opposite Dine Brands and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dine Brands position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.The idea behind Dine Brands Global and Carmell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Carmell Therapeutics vs. Ryanair Holdings PLC | Carmell Therapeutics vs. BJs Restaurants | Carmell Therapeutics vs. Dine Brands Global | Carmell Therapeutics vs. United Guardian |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |